Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) EBT (2020 - 2025)

Historic EBT for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $24.3 million.

  • Cellebrite DI's EBT rose 11187.46% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year increase of 12735.14%. This contributed to the annual value of -$276.0 million for FY2024, which is 26523.7% down from last year.
  • Cellebrite DI's EBT amounted to $24.3 million in Q3 2025, which was up 11187.46% from $20.8 million recorded in Q2 2025.
  • Cellebrite DI's EBT's 5-year high stood at $54.1 million during Q4 2021, with a 5-year trough of -$204.5 million in Q3 2024.
  • For the 5-year period, Cellebrite DI's EBT averaged around -$7.2 million, with its median value being $8.7 million (2021).
  • Its EBT has fluctuated over the past 5 years, first soared by 85390.45% in 2021, then tumbled by 308637.76% in 2024.
  • Over the past 5 years, Cellebrite DI's EBT (Quarter) stood at $54.1 million in 2021, then plummeted by 83.18% to $9.1 million in 2022, then crashed by 235.63% to -$12.3 million in 2023, then surged by 261.17% to $19.9 million in 2024, then grew by 22.07% to $24.3 million in 2025.
  • Its EBT was $24.3 million in Q3 2025, compared to $20.8 million in Q2 2025 and $19.3 million in Q1 2025.